Linden Thomas Advisory Services, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Linden Thomas Advisory Services, LLC
- $789 Billion
- Q4 2024
A detailed history of Linden Thomas Advisory Services, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 32,639 shares of CPRX stock, worth $737,641. This represents 0.09% of its overall portfolio holdings.
Number of Shares
32,639
Previous 26,907
21.3%
Holding current value
$737,641
Previous $535 Million
27.34%
% of portfolio
0.09%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$423 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$191 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$131 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$70.8 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$68.1 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.32B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...